Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Najah S. Alanazi"'
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 6, Pp 735-741 (2022)
Purpose: This study aimed to assess the type, severity, seriousness, reasons, and outcomes of adverse drug reactions (ADRs) in the reports submitted to the regional spontaneous ADR database. Methods: A retrospective observational study was conducted
Externí odkaz:
https://doaj.org/article/b6cffe8367984fdabc8eb66b959a67c5
Autor:
Khalidah A. Alenzi, Wafi F. Albalawi, Tahani S. Alanazi, Najah S. Alanazi, Deemah S. Alsuhaibani, Nouf Almuwallad, Thamir M. Alshammari
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 5, Pp 562-569 (2022)
Background: On March 11th, 2020, The World Health Organization (WHO) declared that the COVID-19 is a pandemic due to its worldwide spread. The COVID-19 pandemic has extended its impact to Saudi Arabia. By mid-February 2021, The Kingdom of Saudi Arabi
Externí odkaz:
https://doaj.org/article/adaa6b6b09af467ba4936fdbf55d9caa
Publikováno v:
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 30(6)
This study aimed to assess the type, severity, seriousness, reasons, and outcomes of adverse drug reactions (ADRs) in the reports submitted to the regional spontaneous ADR database.A retrospective observational study was conducted to analyze all the
Publikováno v:
The American Journal of Case Reports
Patient: Male, 69-year-old Final Diagnosis: Acute renal failure • cholestatic jaundice and myositis induced by fluvastatin • stage 3 chronic kidney disease Symptoms: Abdominal pain, loss of appetite • fatigue • jaundiced and tender in the upp